Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Operating Officer, will participate in the Oppenheimer Summit for Emerging Biotechnology being held June 27-28 in Montauk, New York.
June 20, 2019
· 1 min read